Skip to contentUniversitywide | New Brunswick | RBHS | Newark | Camden | Online
Search result opens in new window

Rutgers University logoGo to Rutgers University site

Summer Undergraduate Research Fellowship

Ernest Mario School of Pharmacy

  • Home
  • Overview
  • Application
  • Activities
    • Research
    • Enrichment
  • Participants
    • SURF Participants 2022
    • SURF Participants 2021
    • SURF Participants 2020
    • SURF Participants 2019
    • SURF Participants 2018
    • SURF Participants 2017
    • Prior Years
  • Outcomes
    • Publications
    • Symposia
    • Presentations
    • Awards
    • SURFers in the News
    • Education
    • Support
  • News
  • Calendar
  • Gallery
    • SURF 2021
    • SURF 2020
    • SURF 2019
    • SURF 2018

Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery

Posted March 2, 2020, in publications.

Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery

In Heon Lee, SURF 2013

Post navigation

‹ Previous: Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo
Next: Pharmacists improve diabetes outcomes: a randomized controlled trial ›

Admin

Copyright WordPress admin login page© Rutgers, The State University of New Jersey. All rights reserved.

Page last updated by L. Everett at 10:31 am March 2, 2020.

This page was printed from http://surf.rutgers.edu/2020/03/design-and-evaluation-of-a-cxcr4-targeting-peptide-4dv3-as-an-hiv-entry-inhibitor-and-a-ligand-for-targeted-drug-delivery/ at 2:37 AM Monday, February 6, 2023.